Recent studies have uncovered other AKI biomarkers such as neutrophil gelatinase-associated lipocalin [8]; [35]–[37], interleukin-18 [9], liver-type fatty acid binding protein [38]; [39], and kidney injury molecule-1 [40] in clinical cohorts similar to that employed in this study. The gene discussed is LCN2; the disease is acute kidney injury.